Is Spravato Affordable? How the Patient Assistance Program Can Fully Cover Your Medication Costs

If you've been told that Spravato (esketamine) could help your treatment-resistant depression, but the cost feels impossible, you're not alone, and you're not out of options. We want to make it clear that this is not the end of the road. For more than half of our current Spravato patients, insurance coverage was just the beginning of the conversation, not the final answer.

There is a program, the Johnson & Johnson Patient Assistance Program, that can cover the full cost of your Spravato medication itself. While the program doesn’t cover in‑clinic administration time, it can make the medication cost manageable for many patients. It's real, it's accessible, it's something we navigate with you, and it has helped more of our patients than you might expect. The process is not scary. And we handle the heavy lifting.

It’s important to note that the program applies to the medication cost, not the clinical administration fees, which vary by provider.

Why the Cost of Spravato Can Feel Overwhelming at First

Spravato is an FDA-approved nasal spray medication made from esketamine, a compound closely related to ketamine. It's prescribed for adults with treatment-resistant depression (TRD), meaning depression that has not responded adequately to at least two different antidepressants. This affects approximately one-third of all adults diagnosed with major depressive disorder, a group that has, for too long, had very few effective options available to them.

Spravato is a relatively new and specialized medication, and at first glance, its cost can seem steep, especially for people whose insurance doesn’t cover it. That initial sticker shock stops many people before they even begin exploring treatment. 

But what most don’t realize is that the listed price is rarely what patients actually pay. At Etherios Therapy, we’ve built a system designed to make Spravato medication financially accessible for those who genuinely need it. A cornerstone of that support is the J&J Patient Assistance Program, which helps many of our patients receive Spravato medication itself at little to no cost.

A Layered System of Support: How Spravato Affordability Actually Works

Before diving into the Patient Assistance Program specifically, it helps to understand the broader financial support structure that surrounds Spravato. Three primary programs work together to make this medication accessible.

The first is Spravato withMe, a manufacturer-sponsored program that every Spravato patient at our clinic is enrolled in automatically. This program works in conjunction with commercial insurance coverage to bring the patient's medication cost down dramatically, often to as low as $10 per treatment session. For patients whose insurance covers Spravato without issue, Spravato withMe is typically the only financial tool they need.

The second is the Observation Rebate Program (ORP), which provides additional support related to the required in-office monitoring time associated with each Spravato session. Because the medication is administered in a certified clinical setting and patients are observed for two hours following each treatment, this program helps offset administration‑related costs, not the medication itself.

The third (the one we're focusing on today) is the J&J Patient Assistance Program (PAP). This program is specifically designed for patients whose insurance has denied coverage for the Spravato medication itself. And it is, in our experience, one of the most impactful resources available to anyone pursuing Spravato treatment.

What Is the J&J Patient Assistance Program and What Does It Cover?

The Johnson & Johnson Patient Assistance Program is offered by Johnson & Johnson, the maker of Spravato, that provides eligible patients with their medication at absolutely no cost. Not discounted. Not reduced. Free.

It is designed for patients who are uninsured or who have insurance that has denied coverage for their prescribed J&J medication. When a patient is approved for the PAP, J&J covers the full cost of the Spravato medication itself. That means the box of Spravato is no charge to the patient, regardless of what their insurance situation looks like.

This is a well-established, actively used resource. At Etherios Therapy, a meaningful portion of our Spravato patients receive their medication through the Patient Assistance Program. That's a testament to how accessible this program actually is and how committed J&J has been to making Spravato reachable for the people who need it most.

Who Qualifies for the Patient Assistance Program?

According to the program's eligibility requirements, patients may qualify for free Spravato medication for up to one year if they meet the following criteria:

You must live in the United States, Puerto Rico, or the US Virgin Islands and be treated as an outpatient by a US-licensed healthcare provider. You must have been prescribed an eligible J&J medication, which Spravato is, and you must meet the income eligibility threshold, which is set at or below 300% of the Federal Poverty Level (FPL). For 2026, that means a single-person household with an annual gross income up to approximately $46,950 qualifies; for a household of four, the limit rises to approximately $96,450.

Patients with Medicare Part D coverage who fall below 150% of FPL may also need to demonstrate that they are not eligible for the Low-Income Subsidy (LIS), also known as Extra Help, as a prerequisite for PAP enrollment. The program documentation walks through exactly how to verify and document this.

Importantly, the program is available to patients who have insurance, even government insurance like Medicare or Medicaid, as long as that insurance has denied coverage for the Spravato medication. The denial is not a dead end. It is, in many cases, the gateway to getting help through the PAP.

How the Application Process Works and Why It's Not as Complicated as It Sounds

If your insurance denies coverage for Spravato, Etherios Therapy begins the PAP application process as a normal next step. We think of this as a routine part of our Spravato onboarding for patients in this situation, not an emergency workaround, not a last resort, just the next thing on the checklist.

Here is what the process looks like in practice:

Your part is straightforward. You'll need to complete and sign page two of the Patient Assistance Enrollment Form, which covers your basic personal and financial information. Along with that, you'll provide a copy of your most recent federal tax return (Form 1040 or 1040-SR) and a copy of your insurance card. That's it on your end.

Our team handles the rest. We submit the completed application along with the insurance denial letter from your insurer and clinical notes from your provider. The application goes directly to J&J, which then reviews your eligibility and decides.

When approved, and the majority of our patients are approved, J&J covers the full cost of the Spravato medication itself. Your sessions at our clinic continue as planned, and the financial barrier that felt so enormous simply disappears.

What Happens If the Application Is Denied? There's Still a Path Forward

In the rare cases where an initial PAP application is not approved, we do not consider that the end of the process. J&J allows for written appeals, and our team can submit one on your behalf. In that appeal, we document the financial reality clearly, including the out-of-pocket cost of Spravato medication without assistance and what that would mean for a patient's ability to continue treatment.

We have seen very few definitive denials from J&J. Most appeals are reconsidered favorably. It speaks to what this program actually is at its core: a genuine effort by the manufacturer to get this medication to patients who need it but cannot afford it without help.

We want you to know that if you end up in an appeal situation, you are not navigating it alone. Our team writes the appeal. You don't have to know the right words or the right framing. We do this regularly, and we will advocate for you.

This Is Not Scary: We Guide You Through Every Step

We understand that navigating insurance denials and financial assistance programs can feel overwhelming, especially when you're also dealing with a mental health condition that has already proven resistant to standard treatments. That is exactly why we've built our process the way we have so that the financial path to Spravato medication is as smooth and as clear as possible.

When your insurance denies the Spravato medication, we will let you know that we've seen this before, many times, and that there is a very good chance the PAP will step in to cover the medication cost. We will walk you through the paperwork together. We will submit the application with you. We will follow up. And when you're approved, we will make sure your treatment continues without interruption.

You deserve access to a treatment that may genuinely change the course of your depression. Spravato has been shown to produce meaningful symptom improvement in as little as 24 hours, with sustained improvements continuing through four weeks and beyond. The FDA's approval of Spravato as the first standalone monotherapy for treatment-resistant depression in January 2025 was a landmark moment in mental health care. We believe that financial obstacles should not stand between you and that kind of relief.

The cost of Spravato does not have to be your burden to carry alone. The Patient Assistance Program exists precisely so it doesn't have to be.

Ready to Learn More About Starting Spravato at Etherios Therapy?

If you've been struggling with treatment-resistant depression and wondering whether Spravato could be right for you and whether you could afford it, we want to have that conversation. The answer, more often than not, is yes.

Etherios Therapy in Orem, Utah, is experienced in guiding patients through the full Spravato process, from your first consultation to your ongoing treatment sessions, including every step of the financial support process for Spravato medication. 

We accept a wide range of insurance plans, and when insurance falls short, we know exactly how to help you find the coverage that fills the gap for your Spravato prescription. You can learn more about our Spravato treatment program or explore our insurance and coverage information to get a sense of what to expect.

When you're ready, we're here. Reach out to our team online, or give us a call at 801-960-3131. Let's talk about what's possible.